# Nuevocor Pte.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nuevocor-pte

- Industry: Biotechnology
- Headquarters: Singapore, Singapore
- Website: www.nuevocor.com
- Total disclosed funding: $50M
- Latest round: Series B (Sep 16, 2025)
- Investors on record: 10

## About

Founded in 2021 and based in Singapore, Nuevocor specializes in creating genetic medicines for untreatable genetic cardiomyopathies by leveraging insights from our PrOSIA mechanobiology platform.

## Funding rounds

- Series B, Sep 16, 2025, $26M — SG Growth Capital, Boehringer Ingelheim Venture, Kurma Partners, SEEDS Capital, Xora Innovation, Angelini Ventures, ClavystBio
- Series A, Dec 21, 2022, $16M — SG Growth Capital, Boehringer Ingelheim Venture, Hyfinity Investments, SEEDS Capital, Xora Innovation, ClavystBio, Everjoy Fortune Pte. Ltd.
- Series A, Jul 2, 2021, $8M — SG Growth Capital, Boehringer Ingelheim Venture, Hyfinity Investments, SEEDS Capital, EVX Ventures, Xora Innovation, Everjoy Fortune Pte. Ltd.

## Investors

- SG Growth Capital (https://capitalatlas.ai/funds/sg-growth-capital) — Series A, Series B
- Boehringer Ingelheim Venture (https://capitalatlas.ai/funds/boehringer-ingelheim-venture) — Series A, Series B
- Hyfinity Investments (https://capitalatlas.ai/funds/hyfinity-investments) — Series A
- SEEDS Capital (https://capitalatlas.ai/funds/seeds-capital) — Series A, Series B
- EVX Ventures (https://capitalatlas.ai/funds/evx-ventures) — Series A
- Xora Innovation (https://capitalatlas.ai/funds/xora-innovation) — Series A, Series B
- Everjoy Fortune Pte. Ltd. — Series A
- ClavystBio (https://capitalatlas.ai/funds/clavystbio) — Series A, Series B
- Kurma Partners (https://capitalatlas.ai/funds/kurma-partners) — Series B
- Angelini Ventures (https://capitalatlas.ai/funds/angelini-ventures) — Series B